Medicine and Dentistry
Patient
60%
In Vitro
55%
Emergency
50%
Heart Output
50%
Laparotomy
50%
DNA
50%
Fluid Therapy
50%
Antibody-Drug Conjugate
50%
Triple Negative Breast Cancer
50%
Epidermal Growth Factor Receptor
50%
Cancer Growth
50%
Cyclin-Dependent Kinase
50%
Therapeutic Procedure
31%
Tumor Xenograft
21%
Therapeutics
21%
Toxicity
21%
Cancer Cell Line
16%
B-Cell Chronic Lymphocytic Leukemia
16%
Leukemia Cell
16%
Benzodiazepine
16%
DNA Base
16%
Cells
15%
Cyclin Dependent Kinase Inhibitor
15%
Surgical Emergency
14%
Infusion Fluid
14%
Mortality
14%
Hemodynamic
14%
Intervention Trial
14%
Chemotherapy
10%
Cell Cycle
10%
Transcriptomics
10%
Tumor Cell
10%
Breast Cancer
10%
Elective Surgery
7%
Technology Assessment
7%
Hospital
7%
Morbidity
7%
Randomized Controlled Trial
7%
Health Technology
7%
Mortality Rate
7%
Complication
7%
Health
7%
Proliferating Cell Nuclear Antigen
5%
Tumor Spheroid
5%
Xenograft
5%
Analysis
5%
Cyclin E
5%
Immunocompetent Cell
5%
Tumor Progression
5%
Oncogene
5%
Pharmacology, Toxicology and Pharmaceutical Science
Antibody Drug Conjugate
100%
Cytotoxicity
55%
Antitumor Activity
50%
Cyclin Dependent Kinase
50%
Hydrophobicity
50%
Chemotherapy
10%
Benzodiazepine
8%
RNA-Sequencing
5%
Cyclin Dependent Kinase 4
5%
Cellular Imaging
5%
